13473-51-3 Usage
Uses
Used in Pharmaceutical Industry:
(3beta,5beta)-3-[(6-deoxy-4-O-beta-D-glucopyranosyl-alpha-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide is used as a pharmaceutical agent for its potential anticancer, anti-inflammatory, and cardiovascular activities. Its unique chemical structure and properties make it a promising candidate for drug discovery and development.
Used in Drug Delivery Systems:
(3beta,5beta)-3-[(6-deoxy-4-O-beta-D-glucopyranosyl-alpha-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide can be used in drug delivery systems to improve the delivery, bioavailability, and therapeutic outcomes of the compound. Various organic and metallic nanoparticles can be employed as carriers for the delivery of this complex cardenolide glycoside, enhancing its efficacy in treating various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 13473-51-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,4,7 and 3 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 13473-51:
(7*1)+(6*3)+(5*4)+(4*7)+(3*3)+(2*5)+(1*1)=93
93 % 10 = 3
So 13473-51-3 is a valid CAS Registry Number.
13473-51-3Relevant articles and documents
SYNTHESIS OF CONVALLOSIDE
Makarevich, I. F.,Terno, I. S.
, p. 323 - 325 (2007/10/02)
The known natural diglycoside convalloside - strophanthidin 3β-O- - has been synthesized.The synthesis was carried out by the Koenigs-Knorr method via the preparation as intermediates of convallatoxin and its 2,3-isopropylidene derivative.Selectivity of glycosylation was achieved by the preliminary protection of the two OH groups in the cardenolide L-rhamnoside (convallatoxin).